CD4 and non-small cell lung carcinoma: Ye et al. found that the number of CTCs in stage IV NSCLC patients negatively correlates with the number of NK cells and CD3+, CD4+, and CD4+/CD8+ lymphocytes, while a positive correlation was found with the number of Treg cells [201].